In some cancers, such as melanomas and gliomas, SPARC is associated with a highly aggressive tumor phenotype, while in others, mainly ovarian cancer, neuroblastoma and colorectal cancer, SPARC may function as a tumor suppressor [127-129]. Here, SPARC is linked to ovarian carcinoma.